SCHEMBL29114873

SCHEMBL29114873

CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(Nc5ccccc5NS(C)(=O)=O)n4)c(OC(F)C(F)F)n3)CC2)CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 9/20 0.74
▸ ROS1 P08922 7/20 0.74
▸ EGFR P00533 12/20 0.68
▸ INSR P06213 3/20 0.57
▸ IGF1R P08069 2/20 0.57
▸ FGFR1 P11362 2/20 0.55
▸ FGFR2 P21802 2/20 0.55
▸ FGFR4 P22455 2/20 0.55
▸ FGFR3 P22607 2/20 0.55
▸ BMPR1B O00238 1/20 0.54
▸ PLK4 O00444 1/20 0.54
▸ STK25 O00506 1/20 0.54
▸ RIOK3 O14730 1/20 0.54
▸ CHEK1 O14757 1/20 0.54
▸ CASK O14936 1/20 0.54
▸ AURKA O14965 1/20 0.54
▸ GAK O14976 1/20 0.54
▸ DCLK1 O15075 1/20 0.54
▸ MUSK O15146 1/20 0.54
▸ EPHB6 O15197 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29245739 0.88 INSR (0.69) ALKROS1EGFRINSRIGF1R
SCHEMBL26906653 0.88 ALK (0.69) ALKROS1EGFRINSRIGF1R
SCHEMBL29904632 0.83 ALK (0.71) ALKROS1EGFRINSRIGF1R
SCHEMBL26906765 0.83 ALK (0.71) ALKROS1EGFRINSRIGF1R
SCHEMBL29114866 0.83 EGFR (0.70) ALKROS1EGFRINSRIGF1R
SCHEMBL29904622 0.83 EGFR (0.70) ALKROS1EGFRINSRIGF1R
SCHEMBL21846986 0.81 EGFR (1.00) ALKROS1EGFRINSRIGF1R
SCHEMBL22462105 0.80 ALK (0.77) ALKROS1EGFRINSRIGF1R
SCHEMBL29245829 0.80 ALK (0.64) ALKROS1EGFRINSRIGF1R
SCHEMBL29904644 0.80 ALK (0.68) ALKROS1EGFRINSRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120424-A Pyrimidine derivatives having protein kinase inhibitory activity and therapeutic combinations comprising the same 泰拉佩克斯有限公司 2023-11-24 — — CN claimed
CN-117120424-A Pyrimidine derivatives having protein kinase inhibitory activity and therapeutic combinations comprising the same 泰拉佩克斯有限公司 2023-11-24 — — CN disclosed
Send feedback